Showing results (1-10 of 330) with videos related to
Sort By:
Pageof 33
International Journal of Radiation Oncology, Biology, Physics|January 10, 2009
Gleason Pattern 5 prostate cancer: further stratification of patients with high-risk disease and implications for future randomized trialsAkash Nanda, Ming-Hui Chen, Andrew A Renshaw, et al.JAMA|August 27, 2009
Hormonal therapy use for prostate cancer and mortality in men with coronary artery disease-induced congestive heart failure or myocardial infarctionAkash Nanda, Ming-Hui Chen, Michelle H Braccioforte, et al.International Journal of Radiation Oncology, Biology, Physics|January 22, 2013
Cardiovascular comorbidity and mortality in men with prostate cancer treated with brachytherapy-based radiation with or without hormonal therapyAkash Nanda, Ming-Hui Chen, Brian J Moran, et al.Clinical Genitourinary Cancer|May 25, 2015
Whole Pelvis Versus Prostate-Only Radiotherapy With or Without Short-Course Androgen Deprivation Therapy and Mortality RiskLior Z Braunstein, Ming-Hui Chen, Daniel E Dosoretz, et al.European Urology|September 18, 2012
Neoadjuvant hormonal therapy use and the risk of death in men with prostate cancer treated with brachytherapy who have no or at least a single risk factor for coronary artery diseaseAkash Nanda, Ming-Hui Chen, Brian J Moran, et al.International Journal of Radiation Oncology, Biology, Physics|June 23, 2009
Total androgen blockade versus a luteinizing hormone-releasing hormone agonist alone in men with high-risk prostate cancer treated with radiotherapyAkash Nanda, Ming-Hui Chen, Brian J Moran, et al.International Journal of Radiation Oncology, Biology, Physics|September 12, 2009
Predictors of prostate cancer-specific mortality in elderly men with intermediate-risk prostate cancer treated with brachytherapy with or without external beam radiation therapyAkash Nanda, Ming-Hui Chen, Brian J Moran, et al.Urology|September 17, 2002
Radiation and hormonal therapy for locally advanced and clinically localized prostate cancerAnthony V D'AmicoEuropean Urology|September 15, 2015
Is Gleason Grade 5 Prostate Cancer Resistant to Conventional Androgen Deprivation Therapy?Anthony V D'AmicoReviews in Urology|September 21, 2006
Therapeutic strategies for localized and locally advanced prostate cancer: combining androgen suppression with definitive local therapyAnthony V D'AmicoPageof 33